235 related articles for article (PubMed ID: 24611115)
1. Campylobacter jejuni infection of infant mice: acute enterocolitis is followed by asymptomatic intestinal and extra-intestinal immune responses.
Haag LM; Fischer A; Otto B; Grundmann U; Kühl AA; Göbel UB; Bereswill S; Heimesaat MM
Eur J Microbiol Immunol (Bp); 2012 Mar; 2(1):2-11. PubMed ID: 24611115
[TBL] [Abstract][Full Text] [Related]
2. Intestinal microbiota shifts towards elevated commensal Escherichia coli loads abrogate colonization resistance against Campylobacter jejuni in mice.
Haag LM; Fischer A; Otto B; Plickert R; Kühl AA; Göbel UB; Bereswill S; Heimesaat MM
PLoS One; 2012; 7(5):e35988. PubMed ID: 22563475
[TBL] [Abstract][Full Text] [Related]
3. Survey of extra-intestinal immune responses in asymptomatic long-term Campylobacter jejuni-infected mice.
Heimesaat MM; Haag LM; Fischer A; Otto B; Kühl AA; Göbel UB; Bereswill S
Eur J Microbiol Immunol (Bp); 2013 Sep; 3(3):174-82. PubMed ID: 24265935
[TBL] [Abstract][Full Text] [Related]
4. The role of serine protease HtrA in acute ulcerative enterocolitis and extra-intestinal immune responses during Campylobacter jejuni infection of gnotobiotic IL-10 deficient mice.
Heimesaat MM; Alutis M; Grundmann U; Fischer A; Tegtmeyer N; Böhm M; Kühl AA; Göbel UB; Backert S; Bereswill S
Front Cell Infect Microbiol; 2014; 4():77. PubMed ID: 24959425
[TBL] [Abstract][Full Text] [Related]
5. Novel murine infection models provide deep insights into the "ménage à trois" of Campylobacter jejuni, microbiota and host innate immunity.
Bereswill S; Fischer A; Plickert R; Haag LM; Otto B; Kühl AA; Dasti JI; Zautner AE; Muñoz M; Loddenkemper C; Gross U; Göbel UB; Heimesaat MM
PLoS One; 2011; 6(6):e20953. PubMed ID: 21698299
[TBL] [Abstract][Full Text] [Related]
6. Campylobacter jejuni induces acute enterocolitis in gnotobiotic IL-10-/- mice via Toll-like-receptor-2 and -4 signaling.
Haag LM; Fischer A; Otto B; Plickert R; Kühl AA; Göbel UB; Bereswill S; Heimesaat MM
PLoS One; 2012; 7(7):e40761. PubMed ID: 22808254
[TBL] [Abstract][Full Text] [Related]
7. The impact of serine protease HtrA in apoptosis, intestinal immune responses and extra-intestinal histopathology during Campylobacter jejuni infection of infant mice.
Heimesaat MM; Fischer A; Alutis M; Grundmann U; Boehm M; Tegtmeyer N; Göbel UB; Kühl AA; Bereswill S; Backert S
Gut Pathog; 2014; 6():16. PubMed ID: 24883112
[TBL] [Abstract][Full Text] [Related]
8. Murine Fecal Microbiota Transplantation Alleviates Intestinal and Systemic Immune Responses in
Heimesaat MM; Mrazek K; Bereswill S
Front Immunol; 2019; 10():2272. PubMed ID: 31616437
[TBL] [Abstract][Full Text] [Related]
9. Protease Activity of
Schmidt AM; Escher U; Mousavi S; Boehm M; Backert S; Bereswill S; Heimesaat MM
Front Cell Infect Microbiol; 2019; 9():79. PubMed ID: 30984628
[TBL] [Abstract][Full Text] [Related]
10. Treatment with the Probiotic Product Aviguard
Heimesaat MM; Weschka D; Mousavi S; Bereswill S
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206478
[TBL] [Abstract][Full Text] [Related]
11. Absence of Nucleotide-Oligomerization-Domain-2 Is Associated with Less Distinct Disease in
Heimesaat MM; Grundmann U; Alutis ME; Fischer A; Bereswill S
Front Cell Infect Microbiol; 2017; 7():322. PubMed ID: 28752081
[TBL] [Abstract][Full Text] [Related]
12. Transplanted human fecal microbiota enhanced Guillain Barré syndrome autoantibody responses after Campylobacter jejuni infection in C57BL/6 mice.
Brooks PT; Brakel KA; Bell JA; Bejcek CE; Gilpin T; Brudvig JM; Mansfield LS
Microbiome; 2017 Aug; 5(1):92. PubMed ID: 28789710
[TBL] [Abstract][Full Text] [Related]
13. Murine Models for the Investigation of Colonization Resistance and Innate Immune Responses in Campylobacter Jejuni Infections.
Mousavi S; Bereswill S; Heimesaat MM
Curr Top Microbiol Immunol; 2021; 431():233-263. PubMed ID: 33620654
[TBL] [Abstract][Full Text] [Related]
14. Can microbiota transplantation abrogate murine colonization resistance against Campylobacter jejuni?
Heimesaat MM; Plickert R; Fischer A; Göbel UB; Bereswill S
Eur J Microbiol Immunol (Bp); 2013 Mar; 3(1):36-43. PubMed ID: 24265916
[TBL] [Abstract][Full Text] [Related]
15. The IL-23/IL-22/IL-18 axis in murine Campylobacter jejuni infection.
Heimesaat MM; Grundmann U; Alutis ME; Fischer A; Göbel UB; Bereswill S
Gut Pathog; 2016; 8():21. PubMed ID: 27385977
[TBL] [Abstract][Full Text] [Related]
16. Immunopathological properties of the
Schmidt AM; Escher U; Mousavi S; Tegtmeyer N; Boehm M; Backert S; Bereswill S; Heimesaat MM
Gut Pathog; 2019; 11():24. PubMed ID: 31131028
[TBL] [Abstract][Full Text] [Related]
17. Novel Clinical
Mousavi S; Bereswill S; Heimesaat MM
Microorganisms; 2020 Mar; 8(4):. PubMed ID: 32231139
[No Abstract] [Full Text] [Related]
18. What you eat is what you get: Novel Campylobacter models in the quadrangle relationship between nutrition, obesity, microbiota and susceptibility to infection.
Bereswill S; Plickert R; Fischer A; Kühl AA; Loddenkemper C; Batra A; Siegmund B; Göbel UB; Heimesaat MM
Eur J Microbiol Immunol (Bp); 2011 Sep; 1(3):237-48. PubMed ID: 24516730
[TBL] [Abstract][Full Text] [Related]
19. Human microbiota associated IL-10-/- mice: A valuable enterocolitis model to dissect the interactions of Campylobacter jejuni with host immunity and gut microbiota.
Shayya NW; Foote MS; Langfeld LQ; Du K; Bandick R; Mousavi S; Bereswill S; Heimesaat MM
Eur J Microbiol Immunol (Bp); 2023 Jan; 12(4):107-122. PubMed ID: 36633627
[TBL] [Abstract][Full Text] [Related]
20. Oral curcumin ameliorates acute murine campylobacteriosis.
Heimesaat MM; Mousavi S; Lobo de Sá FD; Peh E; Schulzke JD; Bücker R; Kittler S; Bereswill S
Front Immunol; 2024; 15():1363457. PubMed ID: 38855111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
